Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rotavirus Infections | 35 | 2021 | 287 | 6.950 |
Why?
|
| Gastroenteritis | 28 | 2023 | 300 | 5.210 |
Why?
|
| Rotavirus | 33 | 2021 | 377 | 4.830 |
Why?
|
| Caliciviridae Infections | 22 | 2023 | 279 | 4.700 |
Why?
|
| Norovirus | 23 | 2023 | 287 | 3.250 |
Why?
|
| Organoids | 11 | 2023 | 287 | 2.420 |
Why?
|
| Oligosaccharides | 3 | 2018 | 110 | 1.850 |
Why?
|
| Milk, Human | 5 | 2018 | 277 | 1.730 |
Why?
|
| Polysaccharides | 9 | 2021 | 197 | 1.720 |
Why?
|
| Blood Group Antigens | 6 | 2021 | 90 | 1.310 |
Why?
|
| Viruses | 5 | 2023 | 159 | 1.260 |
Why?
|
| Viral Vaccines | 5 | 2020 | 304 | 1.250 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2023 | 907 | 1.220 |
Why?
|
| Cell Culture Techniques | 6 | 2021 | 598 | 1.220 |
Why?
|
| Capsid Proteins | 10 | 2014 | 185 | 1.180 |
Why?
|
| Antibodies, Viral | 10 | 2020 | 1320 | 1.170 |
Why?
|
| Immunoglobulin A | 6 | 2016 | 237 | 1.140 |
Why?
|
| Intestinal Mucosa | 7 | 2023 | 1081 | 1.120 |
Why?
|
| India | 26 | 2021 | 301 | 1.070 |
Why?
|
| Vaccines, Virus-Like Particle | 2 | 2017 | 30 | 1.060 |
Why?
|
| Rotavirus Vaccines | 6 | 2020 | 67 | 0.940 |
Why?
|
| Diarrhea | 12 | 2018 | 686 | 0.890 |
Why?
|
| Virus Physiological Phenomena | 2 | 2018 | 19 | 0.800 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2018 | 186 | 0.790 |
Why?
|
| Epithelial Cells | 5 | 2021 | 1818 | 0.770 |
Why?
|
| Antigens, Viral | 9 | 2020 | 471 | 0.770 |
Why?
|
| Feces | 17 | 2020 | 770 | 0.750 |
Why?
|
| Intestines | 6 | 2023 | 686 | 0.710 |
Why?
|
| Viral Proteins | 6 | 2021 | 435 | 0.680 |
Why?
|
| Virus Replication | 11 | 2023 | 709 | 0.680 |
Why?
|
| Nurseries, Hospital | 2 | 2008 | 6 | 0.670 |
Why?
|
| Viral Nonstructural Proteins | 6 | 2018 | 163 | 0.660 |
Why?
|
| Enterovirus | 1 | 2019 | 63 | 0.660 |
Why?
|
| Enterovirus Infections | 1 | 2019 | 47 | 0.650 |
Why?
|
| Stem Cells | 6 | 2021 | 1213 | 0.650 |
Why?
|
| Infant, Newborn | 23 | 2021 | 8223 | 0.640 |
Why?
|
| Genotype | 19 | 2021 | 4109 | 0.630 |
Why?
|
| Norwalk virus | 2 | 2015 | 127 | 0.590 |
Why?
|
| Poliovirus Vaccines | 1 | 2016 | 16 | 0.590 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 538 | 0.580 |
Why?
|
| RNA, Viral | 7 | 2012 | 671 | 0.570 |
Why?
|
| Milk | 1 | 2017 | 120 | 0.570 |
Why?
|
| Virus Diseases | 2 | 2021 | 398 | 0.520 |
Why?
|
| Receptors, Virus | 5 | 2018 | 157 | 0.520 |
Why?
|
| Host-Pathogen Interactions | 5 | 2021 | 314 | 0.520 |
Why?
|
| Immunoglobulin G | 6 | 2019 | 1021 | 0.500 |
Why?
|
| Reassortant Viruses | 2 | 2015 | 32 | 0.480 |
Why?
|
| RNA-Binding Proteins | 3 | 2018 | 984 | 0.430 |
Why?
|
| B-Lymphocytes | 2 | 2019 | 1294 | 0.420 |
Why?
|
| Viral Load | 2 | 2010 | 493 | 0.410 |
Why?
|
| Virus Shedding | 2 | 2013 | 88 | 0.410 |
Why?
|
| Humans | 72 | 2023 | 261506 | 0.390 |
Why?
|
| Asymptomatic Infections | 1 | 2010 | 34 | 0.380 |
Why?
|
| Hospitalization | 6 | 2020 | 2083 | 0.370 |
Why?
|
| Viremia | 1 | 2010 | 177 | 0.360 |
Why?
|
| Diarrhea, Infantile | 1 | 2008 | 43 | 0.330 |
Why?
|
| Genome, Viral | 1 | 2009 | 155 | 0.330 |
Why?
|
| Virus Cultivation | 2 | 2019 | 70 | 0.310 |
Why?
|
| Cost of Illness | 2 | 2009 | 498 | 0.300 |
Why?
|
| Intestine, Small | 2 | 2021 | 499 | 0.300 |
Why?
|
| Infant | 18 | 2021 | 13310 | 0.300 |
Why?
|
| Poverty Areas | 1 | 2006 | 37 | 0.290 |
Why?
|
| Antiviral Agents | 3 | 2023 | 1230 | 0.290 |
Why?
|
| Geographic Information Systems | 1 | 2006 | 57 | 0.290 |
Why?
|
| Cross Infection | 2 | 2008 | 544 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2020 | 3639 | 0.280 |
Why?
|
| Mothers | 2 | 2013 | 410 | 0.280 |
Why?
|
| Infant, Premature, Diseases | 1 | 2008 | 245 | 0.280 |
Why?
|
| Gastrointestinal Tract | 3 | 2021 | 324 | 0.270 |
Why?
|
| Cricetulus | 2 | 2018 | 205 | 0.270 |
Why?
|
| Fucosyltransferases | 3 | 2021 | 76 | 0.270 |
Why?
|
| CHO Cells | 2 | 2018 | 311 | 0.260 |
Why?
|
| Urban Population | 1 | 2006 | 269 | 0.260 |
Why?
|
| Gastrointestinal Diseases | 2 | 2021 | 589 | 0.260 |
Why?
|
| Phylogeny | 4 | 2014 | 826 | 0.250 |
Why?
|
| Cricetinae | 2 | 2018 | 706 | 0.250 |
Why?
|
| Cryptosporidium | 2 | 2020 | 47 | 0.250 |
Why?
|
| Culture Media | 2 | 2021 | 319 | 0.240 |
Why?
|
| Species Specificity | 5 | 2017 | 777 | 0.230 |
Why?
|
| Cattle | 4 | 2015 | 783 | 0.220 |
Why?
|
| Drug Discovery | 2 | 2023 | 324 | 0.220 |
Why?
|
| Protein Structure, Tertiary | 3 | 2014 | 1487 | 0.210 |
Why?
|
| Virus Attachment | 3 | 2021 | 42 | 0.210 |
Why?
|
| Animals | 16 | 2023 | 59536 | 0.200 |
Why?
|
| Child, Preschool | 14 | 2021 | 16273 | 0.180 |
Why?
|
| Infant, Premature | 2 | 2020 | 787 | 0.180 |
Why?
|
| Antibodies, Blocking | 1 | 2020 | 91 | 0.180 |
Why?
|
| Peptide Hydrolases | 1 | 2021 | 256 | 0.180 |
Why?
|
| Ceramides | 1 | 2020 | 95 | 0.180 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 2019 | 7 | 0.180 |
Why?
|
| Virus Internalization | 1 | 2020 | 88 | 0.170 |
Why?
|
| Seroepidemiologic Studies | 2 | 2016 | 129 | 0.170 |
Why?
|
| Interferons | 1 | 2020 | 291 | 0.170 |
Why?
|
| Interdisciplinary Research | 1 | 2018 | 8 | 0.160 |
Why?
|
| Transcriptome | 3 | 2021 | 1859 | 0.160 |
Why?
|
| Cell Line | 4 | 2020 | 5114 | 0.160 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 114 | 0.160 |
Why?
|
| Breast Feeding | 2 | 2018 | 239 | 0.160 |
Why?
|
| Glycomics | 2 | 2014 | 27 | 0.160 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 246 | 0.160 |
Why?
|
| Colon | 1 | 2021 | 670 | 0.150 |
Why?
|
| Organ Culture Techniques | 1 | 2018 | 241 | 0.150 |
Why?
|
| Tissue Engineering | 1 | 2020 | 269 | 0.150 |
Why?
|
| N-Acetylneuraminic Acid | 2 | 2014 | 34 | 0.150 |
Why?
|
| Injections, Intramuscular | 1 | 2017 | 255 | 0.140 |
Why?
|
| Organ Specificity | 1 | 2018 | 699 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 5 | 2021 | 3203 | 0.140 |
Why?
|
| Staining and Labeling | 2 | 2014 | 429 | 0.140 |
Why?
|
| Cattle Diseases | 1 | 2015 | 22 | 0.140 |
Why?
|
| Cohort Studies | 6 | 2021 | 9244 | 0.140 |
Why?
|
| Vaccination | 2 | 2020 | 1123 | 0.130 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 541 | 0.130 |
Why?
|
| Acute Disease | 3 | 2020 | 2422 | 0.130 |
Why?
|
| Protein Binding | 3 | 2021 | 3438 | 0.130 |
Why?
|
| Carbohydrate Sequence | 1 | 2014 | 38 | 0.130 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 81 | 0.120 |
Why?
|
| Saliva | 1 | 2015 | 231 | 0.120 |
Why?
|
| Hemagglutination Tests | 1 | 2013 | 33 | 0.120 |
Why?
|
| Protein Conformation | 3 | 2021 | 1258 | 0.120 |
Why?
|
| Travel | 1 | 2014 | 190 | 0.110 |
Why?
|
| Biopsy | 1 | 2020 | 3443 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2015 | 709 | 0.100 |
Why?
|
| Models, Molecular | 3 | 2021 | 1732 | 0.100 |
Why?
|
| Binding Sites | 3 | 2021 | 2171 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 5 | 2010 | 2483 | 0.100 |
Why?
|
| Molecular Sequence Data | 5 | 2010 | 6089 | 0.100 |
Why?
|
| Gene Expression | 1 | 2019 | 3570 | 0.100 |
Why?
|
| Genes, Viral | 2 | 2008 | 202 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 4320 | 0.100 |
Why?
|
| Virology | 1 | 2010 | 32 | 0.100 |
Why?
|
| Biodiversity | 1 | 2010 | 91 | 0.090 |
Why?
|
| Bifidobacterium | 1 | 2010 | 64 | 0.090 |
Why?
|
| Sequence Homology | 1 | 2009 | 71 | 0.090 |
Why?
|
| Prevalence | 5 | 2020 | 3260 | 0.090 |
Why?
|
| Neutralization Tests | 2 | 2020 | 299 | 0.090 |
Why?
|
| Beds | 1 | 2008 | 18 | 0.080 |
Why?
|
| Community-Acquired Infections | 2 | 2007 | 285 | 0.080 |
Why?
|
| Male | 15 | 2020 | 123000 | 0.080 |
Why?
|
| Caliciviridae | 1 | 2007 | 10 | 0.080 |
Why?
|
| Adult | 8 | 2020 | 77950 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 3 | 2020 | 1165 | 0.080 |
Why?
|
| Female | 14 | 2020 | 141928 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 1489 | 0.070 |
Why?
|
| Crystallography, X-Ray | 2 | 2019 | 627 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 4367 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2020 | 488 | 0.070 |
Why?
|
| Cryptosporidiosis | 1 | 2006 | 86 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2006 | 163 | 0.060 |
Why?
|
| Seasons | 1 | 2006 | 340 | 0.060 |
Why?
|
| Hospitals | 1 | 2008 | 485 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2006 | 627 | 0.060 |
Why?
|
| Reference Standards | 1 | 2023 | 339 | 0.050 |
Why?
|
| Biological Assay | 1 | 2023 | 177 | 0.050 |
Why?
|
| Polyproteins | 1 | 2021 | 7 | 0.050 |
Why?
|
| Glycoconjugates | 1 | 2021 | 10 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2010 | 6100 | 0.050 |
Why?
|
| Laminin | 1 | 2021 | 194 | 0.050 |
Why?
|
| Calcitriol | 1 | 2021 | 127 | 0.050 |
Why?
|
| A549 Cells | 1 | 2021 | 124 | 0.050 |
Why?
|
| Proteoglycans | 1 | 2021 | 259 | 0.050 |
Why?
|
| Zoonoses | 2 | 2013 | 55 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 2927 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2020 | 5637 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2021 | 303 | 0.050 |
Why?
|
| Immunization Schedule | 1 | 2020 | 117 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 280 | 0.050 |
Why?
|
| Sporozoites | 1 | 2020 | 4 | 0.050 |
Why?
|
| Oocysts | 1 | 2020 | 8 | 0.050 |
Why?
|
| Glycochenodeoxycholic Acid | 1 | 2020 | 9 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2021 | 210 | 0.050 |
Why?
|
| Genotyping Techniques | 1 | 2020 | 166 | 0.050 |
Why?
|
| Protein Domains | 1 | 2021 | 314 | 0.050 |
Why?
|
| Immunization Programs | 1 | 2020 | 73 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 14889 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2020 | 49 | 0.040 |
Why?
|
| Adsorption | 1 | 2019 | 46 | 0.040 |
Why?
|
| Haplorhini | 1 | 2019 | 130 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2020 | 220 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2021 | 621 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 4971 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2020 | 187 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2019 | 158 | 0.040 |
Why?
|
| Escherichia coli Infections | 1 | 2021 | 241 | 0.040 |
Why?
|
| Bronchi | 1 | 2021 | 326 | 0.040 |
Why?
|
| Chile | 1 | 2018 | 61 | 0.040 |
Why?
|
| Myofibroblasts | 1 | 2020 | 133 | 0.040 |
Why?
|
| Histocompatibility Antigens | 1 | 2018 | 74 | 0.040 |
Why?
|
| Tissue Scaffolds | 1 | 2020 | 135 | 0.040 |
Why?
|
| Immunity | 1 | 2021 | 342 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 275 | 0.040 |
Why?
|
| Fucose | 1 | 2018 | 50 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2020 | 626 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 554 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 752 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2021 | 351 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2018 | 392 | 0.040 |
Why?
|
| Toxins, Biological | 2 | 2007 | 51 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2020 | 323 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 651 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2018 | 469 | 0.040 |
Why?
|
| Bile | 1 | 2016 | 81 | 0.040 |
Why?
|
| Time Factors | 1 | 2010 | 12926 | 0.040 |
Why?
|
| Molecular Typing | 1 | 2016 | 55 | 0.030 |
Why?
|
| Enterocytes | 1 | 2016 | 68 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2021 | 1203 | 0.030 |
Why?
|
| Kobuvirus | 1 | 2014 | 2 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 5539 | 0.030 |
Why?
|
| Glycoproteins | 2 | 2007 | 747 | 0.030 |
Why?
|
| Vaccines, Attenuated | 1 | 2014 | 210 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2014 | 137 | 0.030 |
Why?
|
| Mexico | 1 | 2014 | 259 | 0.030 |
Why?
|
| Young Adult | 3 | 2020 | 21445 | 0.030 |
Why?
|
| HIV Infections | 1 | 2006 | 2134 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2014 | 266 | 0.030 |
Why?
|
| Immunoassay | 1 | 2014 | 216 | 0.030 |
Why?
|
| Placebos | 1 | 2013 | 437 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 3154 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 4233 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 3254 | 0.020 |
Why?
|
| Denaturing Gradient Gel Electrophoresis | 1 | 2010 | 2 | 0.020 |
Why?
|
| Disease Outbreaks | 1 | 2014 | 415 | 0.020 |
Why?
|
| DNA, Ribosomal | 1 | 2010 | 103 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 4053 | 0.020 |
Why?
|
| United States | 2 | 2019 | 15433 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2009 | 94 | 0.020 |
Why?
|
| Base Sequence | 2 | 2007 | 4917 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 980 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 1399 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2014 | 2588 | 0.020 |
Why?
|
| Cats | 1 | 2007 | 166 | 0.020 |
Why?
|
| Sapovirus | 1 | 2007 | 6 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2007 | 34 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 1945 | 0.020 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2007 | 97 | 0.020 |
Why?
|
| Carrier State | 1 | 2007 | 90 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 35 | 0.020 |
Why?
|
| Child | 2 | 2021 | 29154 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2006 | 239 | 0.020 |
Why?
|
| Dogs | 1 | 2007 | 1155 | 0.020 |
Why?
|
| Protozoan Proteins | 1 | 2006 | 114 | 0.020 |
Why?
|
| Middle Aged | 3 | 2020 | 86204 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2009 | 674 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 12873 | 0.010 |
Why?
|
| Mice | 2 | 2019 | 34495 | 0.010 |
Why?
|
| Virulence | 1 | 2004 | 323 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 4758 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2004 | 694 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 31252 | 0.010 |
Why?
|
| Mutation | 1 | 2018 | 15179 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 11538 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 17523 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 5377 | 0.010 |
Why?
|